Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Vor Biopharma Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- −8 vs. Q1 2022
- Shares held
- 31.2M
- +64.9K (+0.2%) vs. Q1 2022
- Total value
- $154.8M
- −$33.1M (−17.6%) vs. Q1 2022
- New holders
- 10
- 11 more added
- Sold out
- 18
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 70 | $0 | 0.00% | −355−83.5% | Reduced |
| Ellevest, Inc. | 46 | $0 | 0.00% | +35+318.2% | Added |
| Credit Suisse AG | 10 | $0 | 0.00% | +10 | New |
| Eagle Bay Advisors LLC | 150 | $746 | 0.00% | +150 | New |
| New York State Common Retirement Fund | 190 | $1.00K | 0.00% | −10,504−98.2% | Reduced |
| Northwestern Mutual Wealth Management Co | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 109 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 759 | $4.00K | 0.00% | −1,669−68.7% | Reduced |
| UBS Group AG | 865 | $4.00K | 0.00% | +865 | New |
| Bank of America Corp | 1,455 | $8.00K | 0.00% | −6,213−81.0% | Reduced |
| Nisa Investment Advisors, LLC | 3,900 | $19.0K | 0.00% | +3,900 | New |
| Bourgeon Capital Management LLC | 7,700 | $38.0K | 0.01% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 10,800 | $54.0K | 0.00% | −4,000−27.0% | Reduced |
| Chicago Partners Investment Group LLC | 12,890 | $59.0K | 0.00% | +26+0.2% | Added |
| Virtu Financial LLC | 12,252 | $61.0K | 0.01% | +12,252 | New |
| Corton Capital Inc. | 14,856 | $74.0K | 0.07% | +4,061+37.6% | Added |
| Delphia (USA) Inc. | 16,132 | $80.0K | 0.06% | +16,132 | New |
| Qube Research & Technologies Ltd | 16,297 | $81.0K | 0.00% | −21,142−56.5% | Reduced |
| Renaissance Technologies LLC | 17,300 | $86.0K | 0.00% | +17,300 | New |
| Northern Trust Corp | 19,026 | $94.0K | 0.00% | −125,941−86.9% | Reduced |
| Tower Research Capital LLC (TRC) | 21,512 | $107.0K | 0.00% | −9,762−31.2% | Reduced |
| LMR Partners LLP | 26,768 | $133.0K | 0.00% | +6,768+33.8% | Added |
| Goldman Sachs Group Inc | 27,532 | $137.0K | 0.00% | +1,925+7.5% | Added |
| Morgan Stanley | 30,270 | $150.0K | 0.00% | +20,143+198.9% | Added |
| State Street Corp | 41,213 | $205.0K | 0.00% | −241,863−85.4% | Reduced |
| Charles Schwab Investment Management Inc | 41,476 | $207.0K | 0.00% | −52,110−55.7% | Reduced |
| Susquehanna International Group, LLP | 53,074 | $264.0K | 0.00% | +53,074 | New |
| Bollard Group LLC | 55,555 | $276.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 69,400 | $345.0K | 0.01% | +69,400 | New |
| Citadel Advisors LLC | 79,374 | $394.0K | 0.00% | +21,765+37.8% | Added |
| Ergoteles LLC | 86,423 | $430.0K | 0.01% | +70,423+440.1% | Added |
| Geode Capital Management, LLC | 107,375 | $533.0K | 0.00% | −149,625−58.2% | Reduced |
| JPMorgan Chase & Co | 171,377 | $852.0K | 0.00% | −11,807−6.4% | Reduced |
| Thrivent Financial for Lutherans | 286,852 | $1.43M | 0.00% | −18,973−6.2% | Reduced |
| Millennium Management LLC | 288,942 | $1.44M | 0.00% | +272,329+1,639.3% | Added |
| OUP Management Co., LLC | 374,714 | $1.86M | 2.56% | 00.0% | Unchanged |
| BlackRock Inc. | 440,118 | $2.19M | 0.00% | −909,127−67.4% | Reduced |
| Artal Group S.A. | 550,000 | $2.73M | 0.15% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 618,000 | $3.07M | 0.31% | −89,010−12.6% | Reduced |
| Vanguard Group Inc | 657,142 | $3.27M | 0.00% | −3,305−0.5% | Reduced |
| OrbiMed Advisors LLC | 833,333 | $4.14M | 0.08% | 00.0% | Unchanged |
| Laurion Capital Management LP | 857,308 | $4.26M | 0.18% | 00.0% | Unchanged |
| Johnson & Johnson | 1,074,658 | $5.34M | 1.36% | 00.0% | Unchanged |
| Woodline Partners LP | 1,111,123 | $5.52M | 0.09% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,138,768 | $5.66M | 0.03% | +1,138,768 | New |
| Paradigm Biocapital Advisors LP | 1,304,300 | $6.48M | 1.29% | +409,896+45.8% | Added |
| FMR LLC | 3,185,653 | $15.8M | 0.00% | +880.0% | Added |
| 5AM Venture Management, LLC | 6,361,723 | $31.6M | 7.82% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 11,120,973 | $55.3M | 1.47% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −82,705−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −55,296−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −63,414−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −55,375−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −32,184−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −40,426−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −16,332−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −12,572−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −10,617−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −9,421−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −8,221−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,083−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,553−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,483−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,166−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |